Abstract:The anti-apoptotic protein survivin is highly expressed in most human cancer cells, but has very low expression in normal differentiated cells. Thus survivin is considered as an attractive cancer drug target. Herein we report the design and synthesis of a series of novel survivin inhibitors based on the oxyquinoline scaffold from our recently identified hit compound UC-112. These new analogs were tested against a panel of cancer cell lines including one with multidrug-resistant phenotype. Eight of these new UC-112 analogs showed IC50 values in the nanomole range in anti-proliferative assays. The best three compounds among them along with UC-112 were submitted for NCI-60 cancer cell line screening. The results indicated that structural modification from UC-112 to our best compound 4g has improved activity by four folds (2.2 mu M for UC-112 vs. 0.5 mu M for 4g, average GI(50) values over all cancer cell lines in the NCI-60 panel). Western blot analyses demonstrated the new compounds maintained high selectivity for survivin inhibition over other members in the inhibition of apoptosis protein family. When tested in an A375 human melanoma xenograft model, the most active compound 4g effectively suppressed tumor growth and strongly induced cancer cell apoptosis in tumor tissues. This novel scaffold is promising for the development of selective survivin inhibitors as potential anticancer agents.

Discovery and Synthesis of Novel Wogonin Derivatives with Potent Antitumor Activity in Vitro.

Design of Wogonin-Inspired Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitors with Potent in Vitro and in Vivo Antitumor Activity.

Synthesis, Evaluation and Quantitative Structure-Activity Relationship (qsar) Analysis of Wogonin Derivatives As Cytotoxic Agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Novel Spiropyrazolone Antitumor Scaffold with Potent Activity: Design, Synthesis and Structure–activity Relationship

Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity.

Synthesis of Novel Diterpenoid Analogs with In-Vivo Antitumor Activity.

Design, synthesis and antitumor activities of oxazolo[5,4-d] pyrimidine derivatives

Synthesis and Antitumor Activity of Scopoletin Derivatives

Synthesis and Biological Evaluation of a Series of Podophyllotoxins Derivatives As a Class of Potent Antitubulin Agents.

Synthesis of Wogonin, a Natural Product with Anticancer Activity

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirotetrahydrothiopyran-Oxindole Derivatives As Potent P53-Mdm2 Inhibitors

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives As Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation

Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

Design, Synthesis And Structure-Activity Relationship Studies Of Novel Survivin Inhibitors With Potent Anti-Proliferative Properties

Design, Synthesis and Pharmacological Evaluation of Β-Carboline Derivatives As Potential Antitumor Agent Via Targeting Autophagy

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Discovery of Novel Polycyclic Spiro-Fused Carbocyclicoxindole-Based Anticancer Agents